Skip to main content
. 2025 May 30;25:267. doi: 10.1186/s12905-025-03829-6

Table 1.

Comparison of demographic and clinical characteristics of patients with upper limb lymphedema and healthy subjects

Lymphedema Group (n = 36)
Mean ± SD
Median (min-max)
n (%)
Healthy Group
(n = 30)
Mean ± SD
Median (min-max)
n (%)
p-value
Demographic Characteristics
Age (years) 58.58 ± 9.11 55.66 ± 6.14 0.127a
Height (cm) 158.13 ± 7.41 161.06 ± 5.00 0.070a
Weight (kg) 73.50 ± 11.62 71.06 ± 7.31 0.324a
BMI (kg/m2) 29.53 ± 5.06 27.51 ± 2.83 0.057a
Marriage status (married) 26 (72.2) 18 (60.0) 0.294b
Working status (working) 4 (11.1) 11 (36.7) 0.014b*
Assessed UL (Dominant) 18 (50.0) 15(50.0) > 0.999b*
Chronic disease (yes) 17 (47.2) 0 (0.0) < 0.001b**
Family history of cancer (yes) 20 (55.6) 2 (6.7) < 0.001b**
Smoking (yes) 2 (5.6) 5 (16.7) 0.231c
Exercise habit (yes) 7 (19.4) 7 (23.3) 0.700b
Disease-Related Characteristics
Time since surgery (years) 5.60 ± 3.51
With lymphedema arm (right) 16 (44.4)

Lymphedema stage (ISL)

Mild

Moderate

Severe

10 (27.8)

13 (36.1)

13 (36.1)

Duration of lymphedema (months) 60.0 (2.00-288.00)
Treatment

Surgical (yes)

Lumpectomy (yes)

Modified radical mastectomy (yes)

Axillar dissection (yes)

36 (100.0)

14 (38.9)

22 (61.1)

36 (100.0)

CT (yes) 36 (100.0)
RT (yes) 36 (100.0)

SD: standard deviation, min: minimum, max: maximum, n: number, BMI: body mass index, cm: centimeter, kg: kilogram, m: meter, UL: Upper Limb, ISL: International Society of Lymphology, CT: chemotherapy, RT: radiotherapy, a: Student’s t-test, b: Chi-square test, c: Fisher’s exact test *: p < 0.05, **p < 0.001